Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery disease

Aims There are limited data on the clinical implications of total physiologic atherosclerotic burden assessed by invasive physiologic studies in patients with coronary artery disease. We investigated the prognostic implications of total physiologic atherosclerotic burden assessed by total sum of fractional flow reserve (FFR) in three vessels (3V-FFR). Methods and results A total of 1136 patients underwent FFR measurement in three vessels (3V FFR-FRIENDS study, NCT01621438). The patients were classified into high and low 3V-FFR groups according to the median value of 3V-FFR (2.72). The primary endpoint was major adverse cardiac events (MACE, a composite of cardiac death, myocardial infarction and ischaemia-driven revascularization) at 2 years. Mean angiographic percent diameter stenosis and FFR were 43.7 ± 19.3% and 0.90 ± 0.08, respectively. There was a negative correlation between 3V-FFR and estimated 2-year MACE rate (P < 0.001). The patients in low 3V-FFR group showed a higher risk of 2-year MACE than those in the high 3V-FFR group [(7.1% vs. 3.8%, hazard ratio (HR) 2.205, 95% confidence interval (CI) 1.201-4.048, P = 0.011]. The higher 2-year MACE rate was mainly driven by the higher rate of ischaemia-driven revascularization in the low 3V-FFR group (6.2% vs. 2.7%, HR 2.568, 95% CI 1.283-5.140, P = 0.008). In a multivariable adjusted model, low 3V-FFR was an independent predictor of MACE (HR 2.031, 95% CI 1.078-3.830, P = 0.029). Conclusion Patients with high total physiologic atherosclerotic burden assessed by 3V-FFR showed higher risk of 2-year clinical events than those with low total physiologic atherosclerotic burden. The difference was mainly driven by ischaemia-driven revascularization for both functionally significant and insignificant lesions at baseline. Three-vessel FFR might be used as a prognostic indicator in patients with coronary artery disease. Clinical trial registration 3V FFR-FRIENDS study (https://clinicaltrials.gov/ct2/show/NCT01621438, NCT01621438).

[1]  J. M. Lee,et al.  Physiologic Assessment of Coronary Artery Disease: Focus on Fractional Flow Reserve , 2016, Korean journal of radiology.

[2]  Takumi Kimura,et al.  The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization. , 2016, Journal of the American College of Cardiology.

[3]  J. M. Lee,et al.  Coronary Flow Reserve and Microcirculatory Resistance in Patients With Intermediate Coronary Stenosis. , 2016, Journal of the American College of Cardiology.

[4]  W. Wijns,et al.  Significance of Intermediate Values of Fractional Flow Reserve in Patients With Coronary Artery Disease , 2016, Circulation.

[5]  P. Serruys,et al.  Usefulness of Coronary Atheroma Burden to Predict Cardiovascular Events in Patients Presenting With Acute Coronary Syndromes (from the PROSPECT Study). , 2015, The American journal of cardiology.

[6]  P. Stella,et al.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. , 2015, European heart journal.

[7]  Jinsun Park,et al.  The relationship between intravascular ultrasound-derived percent total atheroma volume and fractional flow reserve in the intermediate stenosis of proximal or middle left anterior descending coronary artery. , 2015, International journal of cardiology.

[8]  Hongjian Zhu,et al.  Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. , 2014, Journal of the American College of Cardiology.

[9]  William Wijns,et al.  Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. , 2014, European heart journal.

[10]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[11]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI for stable coronary artery disease. , 2014, The New England journal of medicine.

[12]  B. Dimitrov,et al.  Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study , 2014, Circulation. Cardiovascular interventions.

[13]  P. Dagnelie,et al.  Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome. , 2013, Journal of the American College of Cardiology.

[14]  P. Serruys,et al.  Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention. , 2012, JACC. Cardiovascular imaging.

[15]  Daniel S. Berman,et al.  Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography. , 2011, Journal of the American College of Cardiology.

[16]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[17]  Uwe Siebert,et al.  Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .

[18]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[19]  Torsten Hothorn,et al.  On the Exact Distribution of Maximally Selected Rank Statistics , 2002, Comput. Stat. Data Anal..

[20]  K. Gould,et al.  Abnormal Epicardial Coronary Resistance in Patients With Diffuse Atherosclerosis but “Normal” Coronary Angiography , 2001, Circulation.

[21]  N. Mullani,et al.  Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography. , 2000, Circulation.

[22]  B. Gersh.  Functional SYNTAX Score for Risk Assessment in Multivessel Coronary Artery Disease , 2012 .

[23]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .